Looking to publish in Therapeutic Advances In Psychopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowTherapeutic Advances in Psychopharmacology is a peer-reviewed open access journal with a strong clinical and pharmacological focus, aimed at clinicians and researchers in psychopharmacology and providing an online forum for high-quality articles in this area.
Looking to publish in Therapeutic Advances In Psychopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Therapeutic Advances In Psychopharmacology accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
General Reviews
Perspective Reviews
Drug Reviews
Scoping Reviews
Systematic Reviews
Meta-Analyses
Registered Reports – Pre-Data
Registered Reports – Post-Data
Case Reports
Case Series
Brief Reports
Letters To The Editor
Recent Publications
Cariprazine augmentation for negative symptoms of schizophrenia: a prospective analysis and literature review
Ewa Okon-Rocha, David Taylor
Modafinil-associated psychosis: a systematic review of case characteristics and management strategies
Yutaro Sato, Atsushi Sakuma, Hiroaki Tomita
Corrigendum to “Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study”
-
Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians
Kristian Beichmann, Polina Catzeflis, Helena D. Aicher, Federico Seragnoli, Abigail Calder, Adam Amrani, Gregor Hasler
Early suicidal ideation change and suicidality-associated emergency department utilization after ketamine or esketamine treatment in treatment-resistant depression
Liliana Patarroyo-Rodriguez, Vanessa K. Pazdernik, Jennifer L. Vande Voort, Simon Kung, Balwinder Singh
Frequently asked questions
How long does it take to publish?
Accepted articles can appear online within an average of 30 days after APC processing.
Reformat to Therapeutic Advances In Psychopharmacology using Livewrite PremiumIs a cover letter required?
A cover letter is required and should explain why the manuscript is suitable for publication. Writing assistance or third-party submission involvement must also be disclosed in the covering letter.
Reformat to Therapeutic Advances In Psychopharmacology using Livewrite PremiumWhat are the publication costs?
The journal is open access. The standard article processing charge is $3,000 USD, payable after acceptance and before publication. Editorials and Letters to the Editor are free of charge. Plain Language Summary of Publications carry an APC of $4500.
Reformat to Therapeutic Advances In Psychopharmacology using Livewrite Premium